Oxford Pharmascience Group PLC Holding(s) in Company (2665X)
2017年11月22日 - 11:48PM
RNSを含む英国規制内ニュース (英語)
TIDMOXP
RNS Number : 2665X
Oxford Pharmascience Group PLC
22 November 2017
TR-1: Standard form for notification of major holdings
NOTIFICATION OF MAJOR HOLDINGS (to be sent to the relevant
issuer and to the FCA in Microsoft Word format if possible)
--------------------------------------------------------------------------------------------------
1a. Identity of the issuer Oxford Pharmascience Group
or the underlying issuer Plc
of existing shares to which
voting rights are attached:
----------------------------------------------- -------------------------------------------------
1b. Please indicate if the issuer is a non-UK issuer
(please mark with an "X" if appropriate)
--------------------------------------------------------------------------------------------------
Non-UK issuer X
---------------------------------------------------------------------------------- --------------
2. Reason for the notification (please mark the appropriate
box or boxes with an "X")
--------------------------------------------------------------------------------------------------
An acquisition or disposal of voting rights X
---------------------------------------------------------------------------------- --------------
An acquisition or disposal of financial instruments
---------------------------------------------------------------------------------- --------------
An event changing the breakdown of voting rights
---------------------------------------------------------------------------------- --------------
Other (please specify):
---------------------------------------------------------------------------------- --------------
3. Details of person subject to the notification obligation
Name Richard Griffiths and family
City and country of registered St Helier, Jersey
office (if applicable)
4. Full name of shareholder(s) (if different from 3)
--------------------------------------------------------------------------------------------------
Name
----------------------------------------------- -------------------------------------------------
City and country of registered
office (if applicable)
----------------------------------------------- -------------------------------------------------
5. Date on which the threshold 20 November 2017
was crossed or reached:
----------------------------------------------- -------------------------------------------------
6. Date on which issuer notified 22 November 2017
(DD/MM/YYYY):
----------------------------------------------- -------------------------------------------------
7. Total positions of person(s) subject to the notification
obligation
--------------------------------------------------------------------------------------------------
% of voting % of voting Total of Total number
rights attached rights through both in % of voting
to shares financial (8.A + 8.B) rights of
(total of instruments issuer
8. A) (total of
8.B 1 + 8.B
2)
--------------------- ------------------------ ---------------- --------------- --------------
Resulting
situation
on the date
on which
threshold
was crossed
or reached 22.74% 0.00% 22.74% 1,205,661,619
--------------------- ------------------------ ---------------- --------------- --------------
Position
of previous
notification
(if
applicable) 14.18% 0.00% 14.18%
--------------------- ------------------------ ---------------- --------------- --------------
8. Notified details of the resulting situation on the
date on which the threshold was crossed or reached
----------------------------------------------------------------------------------------------------------
A: Voting rights attached to shares
----------------------------------------------------------------------------------------------------------
Class/type Number of voting rights % of voting rights
of
shares
ISIN code
(if possible)
---------------------
Direct Indirect Direct Indirect
(Art 9 of (Art 10 of (Art 9 of (Art 10 of
Directive Directive Directive Directive
2004/109/EC) 2004/109/EC) 2004/109/EC) 2004/109/EC)
(DTR5.1) (DTR5.2.1) (DTR5.1) (DTR5.2.1)
-------------------- ------------------------ -------------- ------------------------- --------------
Ordinary
GB00B3LXPB43 274,170,782 0 22.74% 0.00%
--------------------- ------------------------ -------------- ------------------------- --------------
SUBTOTAL
8. A 274,170,782 22.74%
--------------------- ---------------------------------------- -----------------------------------------
B 1: Financial Instruments according to Art. 13(1)(a)
of Directive 2004/109/EC (DTR5.3.1.1 (a))
----------------------------------------------------------------------------------------------------------
Type of financial Expiration Exercise/ Number of voting % of voting
instrument date Conversion rights that rights
Period(xi) may be acquired
if the instrument
is
exercised/converted.
--------------------- ------------------------ -------------- ------------------------- --------------
SUBTOTAL 8.
B 1
-------------- ------------------------- --------------
B 2: Financial Instruments with similar economic effect
according to Art. 13(1)(b) of Directive 2004/109/EC
(DTR5.3.1.1 (b))
----------------------------------------------------------------------------------------------------------
Type of Expiration Exercise/ Physical Number % of voting
financial date Conversion or cash of voting rights
instrument Period settlement rights
-------------------- ------------------------- -------------- ------------ ----------- --------------
SUBTOTAL
8.B.2
------------ ----------- --------------
9. Information in relation to the person subject to
the notification obligation (please mark the
applicable box with an "X")
Person subject to the notification obligation is
not controlled by any natural person or legal entity
and does not control any other undertaking(s) holding
directly or indirectly an interest in the (underlying)
issuer
Full chain of controlled undertakings through which X
the voting rights and/or the
financial instruments are effectively held starting
with the ultimate controlling natural person or
legal entity (please add additional rows as necessary)
-------------------------------------------------------------- ---------------------
Name % of voting % of voting Total of both
rights if it rights through if it equals
equals or is financial instruments or is higher
higher than if it equals than the notifiable
the notifiable or is higher threshold
threshold than the notifiable
threshold
------------------- ---------------- ----------------------- ---------------------
Richard Griffiths
and family 3.67% 0.00% 3.67%
------------------- ---------------- ----------------------- ---------------------
Blake Holdings
Limited 14.97% 0.00% 14.97%
------------------- ---------------- ----------------------- ---------------------
Cream Capital
Limited 3.49% 0.00% 3.49%
------------------- ---------------- ----------------------- ---------------------
Other Holdings
below the the
3% threshold 0.62% 0.00% 0.62%
------------------- ---------------- ----------------------- ---------------------
10. In case of proxy voting, please identify:
-------------------------------------------------------------------------------------
Name of the proxy holder NA
------------------------------------- ----------------------------------------------
The number and % of voting NA
rights held
------------------------------------- ----------------------------------------------
The date until which the NA
voting rights will be held
------------------------------------- ----------------------------------------------
11. Additional information
-------------------------------------------------------------------------------------
Place of completion St Helier, Jersey
-------------------- ------------------
Date of completion 22 November 2017
-------------------- ------------------
This information is provided by RNS
The company news service from the London Stock Exchange
END
HOLUUSSRBBAAUAA
(END) Dow Jones Newswires
November 22, 2017 09:48 ET (14:48 GMT)
Alba (LSE:ABA)
過去 株価チャート
から 12 2024 まで 1 2025
Alba (LSE:ABA)
過去 株価チャート
から 1 2024 まで 1 2025
Real-Time news about Abaco Capital (ロンドン証券取引所): 0 recent articles
その他のOxford Pharm Gpニュース記事